Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.
An article in Health IT Analytics centered around a study published in this month’s issue of The American Journal of Managed Care® (AJMC®). The study, “Choosing Wisely Clinical Decision Support Adherence and Associated Inpatient Outcomes,” which examined the association between adherence to Choosing Wisely recommendations embedded into clinical decision support alerts and 4 measures of resource and quality, concluded that outcomes improved when physicians followed the computerized results.
Another study in this month’s issue of AJMC®, “Impact of After-Hours Telemedicine on Hospitalizations in a Skilled Nursing Facility,” was included in articles from Clinical Innovation+Technology and mHealth Intelligence. The study found that use of a dedicated virtual after-hours physician coverage service in a skilled nursing facility demonstrated a significant reduction in avoidable hospitalizations.
Community Oncology Alliance put out a press release promoting its recent contributor article for AJMC®. The article, "The Financial Impact of the Sequester Cut to Medicare Part B Drug reimbursement in Community Oncology," reported that community oncology practices have lost $78 million as a result of the ongoing Medicare sequester cut to reimbursement for Part B drugs, which has driven an increase in the number of closings and rate of closure of community oncology practices in the country.
Patient Engagement HIT’s article on price transparency tools highlighted a study published by AJMC®. The study, “Patients’ Views on Price Shopping and Price Transparency,” interviewed patients with access to a price transparency website and found a disconnect between respondents’ enthusiasm for price shopping and their reported use of the price transparency tool to shop for care.
OBR Oncology’s Thursday daily newsfeed included an article from AJMC®’s The Center for Biosimilars®. The article, “Pfizer Calls for FDA Guidance on False or Misleading Information About Biosimilars,” covered Pfizer’s citizen petition to the FDA in which the biosimilar developer asks the agency to issue guidance clarifying how drug sponsors may communicate about biosimilars.
An article from The Heartland Institute mentioned the AJMC® published study, “Personalized Preventive Care Leads to Significant Reductions in Hospital Utilization.” The study assessed the impact of the MDVIP personalized preventive care model on hospital utilization and found that MDVIP members’ rates were substantially lower than nonmembers’.
CMS' 340B Repayment Proposal May Harm Vulnerable Hospitals, Reward Those With Higher Revenues
April 26th 2024The 340B hospitals not receiving an offsetting lump-sum payment from CMS following 2018-2022 cuts later ruled unlawful are disproportionately rural, publicly owned, and nonacademic, according to a new study.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Kaiser Permanente was hit by a data breach in mid-April, impacting 13.4 million health plan members; GlaxoSmithKline (GSK) sued Pfizer and BioNTech for allegedly infringing on its messenger RNA technology patents in the companies’ COVID-19 vaccines; the CDC announced the first-known HIV cases transmitted via cosmetic injections.
Read More